[High levels of atrial natriuretic peptide and copeptin and mortality risk]

Corsino Rey1, Clara García-Cendón2, Pablo Martínez-Camblor3

  • 1Unidad de Cuidados Intensivos Pediátricos, Hospital Universitario Central de Asturias, Oviedo, Asturias, España; Universidad de Oviedo, Oviedo, Asturias, España; Red SAMID II, Instituto de Salud Carlos III, Madrid, España.

Insights

High levels of mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and procalcitonin (PCT) indicate increased mortality risk in critically ill children. MR-proANP showed a stronger association with organ failure than copeptin.

Area of Science:

  • Biomarkers in critical care medicine
  • Pediatric critical illness research
  • Prognostic indicators in intensive care

Background:

  • Biomarkers are crucial for assessing prognosis in critically ill children.
  • Mid-regional pro-atrial natriuretic peptide (MR-proANP), copeptin, and procalcitonin (PCT) are potential indicators of critical illness severity.
  • Understanding the association of these biomarkers with mortality risk is vital for clinical decision-making.

Purpose of the Study:

  • To investigate the association between elevated plasma concentrations of MR-proANP, copeptin, and PCT and the risk of mortality in critically ill children.
  • To compare the predictive value of these biomarkers in relation to mortality risk and organ failure.
  • To evaluate MR-proANP, copeptin, and PCT as prognostic tools in pediatric intensive care.

Main Methods:

  • A prospective observational study was conducted on 254 critically ill children.
  • Plasma concentrations of MR-proANP, copeptin, and PCT were measured.
  • Children were stratified into high (Group A) and low (Group B) mortality risk groups, and by the number of failing organs (Group 1: >1 organ, Group 2: <2 organs).

Main Results:

  • Significantly higher median plasma levels of MR-proANP, copeptin, and PCT were observed in the high mortality risk group (Group A) compared to the low mortality risk group (Group B) (P<.001 for all).
  • The area under the curve (AUC) for differentiating mortality risk was highest for PCT (0.842), followed by MR-proANP (0.764) and copeptin (0.735).
  • MR-proANP demonstrated a statistically significant higher AUC (0.837) than copeptin (0.735) in differentiating between patients with failure of more than 1 organ versus less than 2 organs (P=.01).

Conclusions:

  • Elevated plasma concentrations of MR-proANP, copeptin, and PCT are associated with increased mortality risk in critically ill children.
  • PCT and MR-proANP show strong potential as prognostic biomarkers in this population.
  • MR-proANP exhibits a stronger association with the extent of organ failure compared to copeptin.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.8K